Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of units and pre-funded units Announced: US$60M · US$1.2 a unit · Warrants at US$1.5 for 60 months · Leerink Partners +2 Dealers: Leerink Partners (co-lead), Piper Sandler (co-lead), LifeSci Capital Use of proceeds: Development of clinical and early-stage candidates, particularly TN-201 and TN-401, plus working capital and general corporate purposes | Dec 11, 2025 |